UKONIQ is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Tg Therapeutics, Inc.. The primary component is Umbralisib Tosylate.
Product ID | 73150-200_6f6fcaa4-e82f-4850-bf75-b5806f0478af |
NDC | 73150-200 |
Product Type | Human Prescription Drug |
Proprietary Name | UKONIQ |
Generic Name | Umbralisib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2021-02-05 |
Marketing Category | NDA / NDA |
Application Number | NDA213176 |
Labeler Name | TG Therapeutics, Inc. |
Substance Name | UMBRALISIB TOSYLATE |
Active Ingredient Strength | 260 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-02-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
UKONIQ 88711946 not registered Live/Pending |
TG Therapeutics 2019-12-02 |